Back to Journals » OncoTargets and Therapy » Volume 9

Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma

Total article views   Abstract views HTML views PDF downloads Totals
5,485 Dovepress* 4,020 735+ 1,098 4,755
PubMed Central* 0 730 286 730
Totals 4,020 1,465 1,384 5,485
*Since 15 February 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar